Atlas Trials

Efficacy and Safety of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion in Uncontrolled Type 2 Diabetes

Clinical trial NCT03563794 · UNKNOWN

Trial details

NCT number
NCT03563794
Sponsor
The First Affiliated Hospital of Xiamen University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
T2DM
Start date
2018-06-10
Primary completion
2019-06-10
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.